4-(4-{[2-(Methoxy)phenyl]methyl}phenyl)-1,3-thiazol-2-ylamine

ID: ALA4534106

PubChem CID: 155546998

Max Phase: Preclinical

Molecular Formula: C17H16N2OS

Molecular Weight: 296.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccccc1Cc1ccc(-c2csc(N)n2)cc1

Standard InChI:  InChI=1S/C17H16N2OS/c1-20-16-5-3-2-4-14(16)10-12-6-8-13(9-7-12)15-11-21-17(18)19-15/h2-9,11H,10H2,1H3,(H2,18,19)

Standard InChI Key:  MKMMUGLJSYEIOZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   17.7410   -9.7629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7399  -10.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4547  -11.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1712  -10.5898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1683   -9.7593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4528   -9.3501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8812   -9.3440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5973   -9.7538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5970  -10.5766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3122  -10.9862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0262  -10.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0204   -9.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3046   -9.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0254  -10.9995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2720  -10.6634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7194  -11.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1314  -11.9909    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.9385  -11.8199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8989  -11.1892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2972   -8.5107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0080   -8.0918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 14  2  0
  2 14  1  0
 16 19  1  0
 13 20  1  0
 20 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4534106

    ---

Associated Targets(Human)

LTA4H Tchem Leukotriene A4 hydrolase (1442 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 296.40Molecular Weight (Monoisotopic): 296.0983AlogP: 3.99#Rotatable Bonds: 4
Polar Surface Area: 48.14Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.07CX LogP: 4.45CX LogD: 4.45
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.79Np Likeness Score: -0.99

References

1. Lee KH, Petruncio G, Shim A, Burdick M, Zhang Z, Shim YM, Noble SM, Paige M..  (2019)  Effect of Modifier Structure on the Activation of Leukotriene A4 Hydrolase Aminopeptidase Activity.,  62  (23): [PMID:31751136] [10.1021/acs.jmedchem.9b00663]

Source